Distinct role of Foxo1 in M-CSF- and GM-CSF-differentiated macrophages contributes LPS-mediated IL-10: Implication in hyperglycemia

Journal of Leukocyte Biology

Volumn 97, Issue 2, 2015, Pages 327-339

  Chung, Sangwoon ^a   Ranjan, Ravi ^b   Lee, Yong Gyu ^a   Park, Gye Young ^b   Karpurapu, Manjula ^a   Deng, Jing ^a   Xiao, Lei ^b   Kim, Ji Young ^a   Unterman, Terry G ^c   Christman, John W ^a,c  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Inflammation; M1 like; M2 like; Metabolic stress; Monocyte

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR FKHR; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; FOXO1 PROTEIN, MOUSE; IL10 PROTEIN, HUMAN; IL10 PROTEIN, MOUSE;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; ATHEROSCLEROSIS; ATTENUATION; CELL DIFFERENTIATION; CELL POLARITY; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE EXPRESSION; HYPERGLYCEMIA; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MEDIATOR; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; ANIMAL; CELL LINE; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE ACTIVATION; MALE; MOUSE MUTANT; PATHOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYPERGLYCEMIA; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MICE, OBESE;

EID: 84929176036     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3A0514-251R     Document Type: Article

References (76)

1. Laskin, D. L. (2009) Macrophages and inflammatory mediators in chemical toxicity: A battle of forces. Chem. Res. Toxicol. 22, 1376-1385.
2. Laskin, D. L., Sunil, V. R., Gardner, C. R., Laskin, J. D. (2011) Macrophages and tissue injury: agents of defense or destruction? Annu. Rev. Pharmacol. Toxicol. 51, 267-288.
3. Biswas, S. K., Mantovani, A. (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889-896.
4. Holt, M. P., Cheng, L., Ju, C. (2008) Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J. Leukoc. Biol. 84, 1410-1421.
5. Trujillo, G., O’Connor, E. C., Kunkel, S. L., Hogaboam, C. M. (2008) A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 172, 1209-1221.
6. Ramalingam, T. R., Pesce, J. T., Mentink-Kane, M. M., Madala, S., Cheever, A. W., Comeau, M. R., Ziegler, S. F., Wynn, T. A. (2009) Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin. J. Immunol. 182, 6452-6459.
7. Galli, S. J., Borregaard, N., Wynn, T. A. (2011) Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 12, 1035-1044.
8. Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., Balkwill, F. R. (2008) “Re-educating” tumor-associated macrophages by targeting NF-kappaB. J. Exp. Med. 205, 1261-1268.
9. Kawanishi, N., Yano, H., Yokogawa, Y., Suzuki, K. (2010) Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc. Immunol. Rev. 16, 105-118.
10. Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., Udalova, I. A. (2011) IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12, 231-238.
11. Dejean, A. S., Hedrick, S. M., Kerdiles, Y. M. (2011) Highly specialized role of forkhead box O transcription factors in the immune system. Antioxid. Redox Signal. 14, 663-674.
12. Jacobs, F. M., van der Heide, L. P., Wijchers, P. J., Burbach, J. P., Hoekman, M. F., Smidt, M. P. (2003) FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J. Biol. Chem. 278, 35959-35967.
13. van der Heide, L. P., Smidt, M. P. (2005) Regulation of FoxO activity by CBP/p300-mediated acetylation. Trends Biochem. Sci. 30, 81-86.
14. Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K., Fukamizu, A. (2003) Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl. Acad. Sci. USA 100, 11285-11290.
15. Fan, W., Morinaga, H., Kim, J. J., Bae, E., Spann, N. J., Heinz, S., Glass, C. K., Olefsky, J. M. (2010) FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. EMBO J. 29, 4223-4236.
16. Su, D., Coudriet, G. M., Hyun Kim, D., Lu, Y., Perdomo, G., Qu, S., Slusher, S., Tse, H. M., Piganelli, J., Giannoukakis, N., Zhang, J., Dong, H. H. (2009) FoxO1 links insulin resistance to proinflammatory cytokine IL- 1beta production in macrophages. Diabetes 58, 2624-2633.
17. Mauer, J., Chaurasia, B., Goldau, J., Vogt, M. C., Ruud, J., Nguyen, K. D., Theurich, S., Hausen, A. C., Schmitz, J., Brönneke, H. S., Estevez, E., Allen, T. L., Mesaros, A., Partridge, L., Febbraio, M. A., Chawla, A., Wunderlich, F. T., Brüning, J. C. (2014) Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat. Immunol. 15, 423-430.
18. Lumeng, C. N., Bodzin, J. L., Saltiel, A. R. (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184.
19. Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Red Eagle, A., Vats, D., Brombacher, F., Ferrante, A. W., Chawla, A. (2007) Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447, 1116-1120.
20. Tabas, I., Tall, A., Accili, D. (2010) The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circ. Res. 106, 58-67.
21. Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Wagner, R. A., Greaves, D. R., Murray, P. J., Chawla, A. (2006) Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 4, 13-24.
22. Liang, C. P., Han, S., Okamoto, H., Carnemolla, R., Tabas, I., Accili, D., Tall, A. R. (2004) Increased CD36 protein as a response to defective insulin signaling in macrophages. J. Clin. Invest. 113, 764-773.
23. Biswas, S. K., Mantovani, A. (2012) Orchestration of metabolism by macrophages. Cell Metab. 15, 432-437.
24. Freemerman, A. J., Johnson, A. R., Sacks, G. N., Milner, J. J., Kirk, E. L., Troester, M. A., Macintyre, A. N., Goraksha-Hicks, P., Rathmell, J. C., Makowski, L. (2014) Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J. Biol. Chem. 289, 7884-7896.
25. Hotamisligil, G. S., Erbay, E. (2008) Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 8, 923-934.
26. Bhargava, P., Lee, C. H. (2012) Role and function of macrophages in the metabolic syndrome. Biochem. J. 442, 253-262.
27. Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., Zheng, L., Gardet, A., Tong, Z., Jany, S. S., Corr, S. C., Haneklaus, M., Caffrey, B. E., Pierce, K., Walmsley, S., Beasley, F. C., Cummins, E., Nizet, V., Whyte, M., Taylor, C. T., Lin, H., Masters, S. L., Gottlieb, E., Kelly, V. P., Clish, C., Auron, P. E., Xavier, R. J., O’Neill, L. A. (2013) Succinate is an inflammatory signal that induces IL-1b through HIF-1a. Nature 496, 238-242.
28. Karpurapu M, Wang, X., Deng, J., Park, H., Xiao, L., Sadikot, R. T., Frey, R. S., Maus, U. A., Park, G. Y., Scott, E. W., Christman, J. W. (2011) Functional PU.1 in macrophages has a pivotal role in NF-kB activation and neutrophilic lung inflammation during endotoxemia. Blood 118, 5255-5266.
29. Deng, J., Wang, X., Qian, F., Vogel, S., Xiao, L., Ranjan, R., Park, H., Karpurapu, M., Ye, R. D., Park, G. Y., Christman, J. W. (2012) Protective role of reactive oxygen species in endotoxin-induced lung inflammation through modulation of IL-10 expression. J. Immunol. 188, 5734-5740.
30. Krausgruber, T., Saliba, D., Ryzhakov, G., Lanfrancotti, A., Blazek, K., Udalova, I. A. (2010) IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood 115, 4421-4430.
31. Fleetwood, A. J., Dinh, H., Cook, A. D., Hertzog, P. J., Hamilton, J. A. (2009) GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J. Leukoc. Biol. 86, 411-421.
32. Kanter, J. E., Kramer, F., Barnhart, S., Averill, M. M., Vivekanandan-Giri, A., Vickery, T., Li, L. O., Becker, L., Yuan, W., Chait, A., Braun, K. R., Potter-Perigo, S., Sanda, S., Wight, T. N., Pennathur, S., Serhan, C. N., Heinecke, J. W., Coleman, R. A., Bornfeldt, K. E. (2012) Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc. Natl. Acad. Sci. USA 109, E715-E724.
33. Hahm, E., Li, J., Kim, K., Huh, S., Rogelj, S., Cho, J. (2013) Extracellular protein disulfide isomerase regulates ligand-binding activity of aMb2 integrin and neutrophil recruitment during vascular inflammation. Blood 121, 3789-3800, S1-S15.
34. Tsuchiya, K., Westerterp, M., Murphy, A. J., Subramanian, V., Ferrante, Jr., A. W., Tall, A. R., Accili, D. (2013) Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice. Circ. Res. 112, 992-1003.
35. Deng, X., Zhang, W., O-Sullivan, I., Williams, J. B., Dong, Q., Park, E. A., Raghow, R., Unterman, T. G., Elam, M. B. (2012) FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c. J. Biol. Chem. 287, 20132-20143.
36. Cho, K. W., Morris, D. L., Lumeng, C. N. (2014) Flow cytometry analyses of adipose tissue macrophages. Methods Enzymol. 537, 297-314.
37. Ramkhelawon, B., Hennessy, E. J., Ménager, M., Ray, T. D., Sheedy, F. J., Hutchison, S., Wanschel, A., Oldebeken, S., Geoffrion, M., Spiro, W., Miller, G., McPherson, R., Rayner, K. J., Moore, K. J. (2014) Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity. Nat. Med. 20, 377-384.
38. Seiler, F., Hellberg, J., Lepper, P. M., Kamyschnikow, A., Herr, C., Bischoff, M., Langer, F., Schäfers, H. J., Lammert, F., Menger, M. D., Bals, R., Beisswenger, C. (2013) FOXO transcription factors regulate innate immune mechanisms in respiratory epithelial cells. J. Immunol. 190, 1603-1613.
39. Chung, S., Sundar, I. K., Hwang, J. W., Yull, F. E., Blackwell, T. S., Kinnula, V. L., Bulger, M., Yao, H., Rahman, I. (2011) NF-kB inducing kinase, NIK mediates cigarette smoke/TNFa-induced histone acetylation and inflammation through differential activation of IKKs. PLoS ONE 6, e23488.
40. Sun, Z., Miller, R. A., Patel, R. T., Chen, J., Dhir, R., Wang, H., Zhang, D., Graham, M. J., Unterman, T. G., Shulman, G. I., Sztalryd, C., Bennett, M. J., Ahima, R. S., Birnbaum, M. J., Lazar, M. A. (2012) Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat. Med. 18, 934-942.
41. Shin, D. J., Osborne, T. F. (2009) FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action. J. Biol. Chem. 284, 11110-11120.
42. Lawrence, T., Natoli, G. (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750-761.
43. Fleetwood, A. J., Lawrence, T., Hamilton, J. A., Cook, A. D. (2007) Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: Implications for CSF blockade in inflammation. J. Immunol. 178, 5245-5252.
44. Lari, R., Fleetwood, A. J., Kitchener, P. D., Cook, A. D., Pavasovic, D., Hertzog, P. J., Hamilton, J. A. (2007) Macrophage lineage phenotypes and osteoclastogenesis—complexity in the control by GM-CSF and TGFbeta. Bone 40, 323-336.
45. Wang, T., Ge, Y., Xiao, M., Lopez-Coral, A., Azuma, R., Somasundaram, R., Zhang, G., Wei, Z., Xu, X., Rauscher III F. J, Herlyn, M, Kaurman, R. E. (2012) Melanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature. Pigment Cell Melanoma Res. 25, 493-505.
46. Svensson, J., Jenmalm, M. C., Matussek, A., Geffers, R., Berg, G., Ernerudh, J. (2011) Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. J. Immunol. 187, 3671-3682.
47. McWhorter, F. Y., Wang, T., Nguyen, P., Chung, T., Liu, W. F. (2013) Modulation of macrophage phenotype by cell shape. Proc. Natl. Acad. Sci. USA 110, 17253-17258.
48. Han, M. S., Jung, D. Y., Morel, C., Lakhani, S. A., Kim, J. K., Flavell, R. A., Davis, R. J. (2013) JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339, 218-222.
49. Nagashima, T., Shigematsu, N., Maruki, R., Urano, Y., Tanaka, H., Shimaya, A., Shimokawa, T., Shibasaki, M. (2010) Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol. Pharmacol. 78, 961-970.
50. Kawano, Y., Nakae, J., Watanabe, N., Fujisaka, S., Iskandar, K., Sekioka, R., Hayashi, Y., Tobe, K., Kasuga, M., Noda, T., Yoshimura, A., Itoh, H. (2012) Loss of Pdk1-Foxo1 signaling in myeloid cells predisposes to adipose tissue inflammation and insulin resistance. Diabetes 61, 1935-1948.
51. Shanmugam, N., Reddy, M. A., Guha, M., Natarajan, R. (2003) High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52, 1256-1264.
52. Mantovani, A. (2008) From phagocyte diversity and activation to probiotics: Back to Metchnikoff. Eur. J. Immunol. 38, 3269-3273.
53. Hamilton, J. A., Stanley, E. R., Burgess, A. W., Shadduck, R. K. (1980) Stimulation of macrophage plasminogen activator activity by colonystimulating factors. J. Cell. Physiol. 103, 435-445.
54. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., Steinman, R. M. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693-1702.
55. Battiprolu, P. K., Hojayev, B., Jiang, N., Wang, Z. V., Luo, X., Iglewski, M., Shelton, J. M., Gerard, R. D., Rothermel, B. A., Gillette, T. G., Lavandero, S., Hill, J. A. (2012) Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J. Clin. Invest. 122, 1109-1118.
56. Barthel, A., Schmoll, D., Unterman, T. G. (2005) FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 16, 183-189.
57. Sengupta, A., Molkentin, J. D., Yutzey, K. E. (2009) FoxO transcription factors promote autophagy in cardiomyocytes. J. Biol. Chem. 284, 28319-28331.
58. Lehmann, O. J., Sowden, J. C., Carlsson, P., Jordan, T., Bhattacharya, S. S. (2003) Fox’s in development and disease. Trends Genet. 19, 339-344.
59. Hedrick, S. M., Hess Michelini, R., Doedens, A. L., Goldrath, A. W., Stone, E. L. (2012) FOXO transcription factors throughout T cell biology. Nat. Rev. Immunol. 12, 649-661.
60. Essaghir, A., Dif, N., Marbehant, C. Y., Coffer, P. J., Demoulin, J. B. (2009) The transcription of FOXO genes is stimulated by FOXO3 and repressed by growth factors. J. Biol. Chem. 284, 10334-10342.
61. Hedrick, S. M. (2009) The cunning little vixen: Foxo and the cycle of life and death. Nat. Immunol. 10, 1057-1063.
62. Lin, L., Hron, J. D., Peng, S. L. (2004) Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21, 203-213.
63. Ouyang, W., Li, M. O. (2011) Foxo: in command of T lymphocyte homeostasis and tolerance. Trends Immunol. 32, 26-33.
64. Tsuchiya, K., Banks, A. S., Liang, C. P., Tabas, I., Tall, A. R., Accili, D. (2011) Homozygosity for an allele encoding deacetylated FoxO1 protects macrophages from cholesterol-induced inflammation without increasing apoptosis. Arterioscler. Thromb. Vasc. Biol. 31, 2920-2928.
65. Senokuchi, T., Liang, C. P., Seimon, T. A., Han, S., Matsumoto, M., Banks, A. S., Paik, J. H., DePinho, R. A., Accili, D., Tabas, I., Tall, A. R. (2008) Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress. Diabetes 57, 2967-2976.
66. Baumgartl, J., Baudler, S., Scherner, M., Babaev, V., Makowski, L., Suttles, J., McDuffie, M., Tobe, K., Kadowaki, T., Fazio, S., Kahn, C. R., Hotamisligil, G. S., Krone, W., Linton, M., Br ¨uning, J. C. (2006) Myeloid lineage cell-restricted insulin resistance protects apolipoproteinEdeficient mice against atherosclerosis. Cell Metab. 3, 247-256.
67. Osborn, O., Olefsky, J. M. (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18, 363-374.
68. Fujisaka, S., Usui, I., Bukhari, A., Ikutani, M., Oya, T., Kanatani, Y., Tsuneyama, K., Nagai, Y., Takatsu, K., Urakaze, M., Kobayashi, M., Tobe, K. (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58, 2574-2582.
69. Li, P., Lu, M., Nguyen, M. T., Bae, E. J., Chapman, J., Feng, D., Hawkins, M., Pessin, J. E., Sears, D. D., Nguyen, A. K., Olefsky, J. M. (2010) Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J. Biol. Chem. 285, 15333-15345.
70. Patsouris, D., Li, P. P., Thapar, D., Chapman, J., Olefsky, J. M., Neels, J. G. (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 8, 301-309.
71. Juge-Aubry, C. E., Somm, E., Giusti, V., Pernin, A., Chicheportiche, R., Verdumo, C., Rohner-Jeanrenaud, F., Burger, D., Dayer, J. M., Meier, C. A. (2003) Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 52, 1104-1110.
72. Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., Akasaki, Y., Shimono, A., Walsh, K. (2010) Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454-457.
73. Esposito, K., Pontillo, A., Giugliano, F., Giugliano, G., Marfella, R., Nicoletti, G., Giugliano, D. (2003) Association of low interleukin-10 levels with the metabolic syndrome in obese women. J. Clin. Endocrinol. Metab. 88, 1055-1058.
74. Calcaterra, V., De Amici, M., Klersy, C., Torre, C., Brizzi, V., Scaglia, F., Albanesi, M., Albertini, R., Allais, B., Larizza, D. (2009) Adiponectin, IL- 10 and metabolic syndrome in obese children and adolescents. Acta Biomed. 80, 117-123.
75. Hong, E. G., Ko, H. J., Cho, Y. R., Kim, H. J., Ma, Z., Yu, T. Y., Friedline, R. H., Kurt-Jones, E., Finberg, R., Fischer, M. A., Granger, E. L., Norbury, C. C., Hauschka, S. D., Philbrick, W. M., Lee, C. G., Elias, J. A., Kim, J. K. (2009) Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 58, 2525-2535.
76. Grant, L., Shearer, K. D., Czopek, A., Lees, E. K., Owen, C., Agouni, A., Workman, J., Martin-Granados, C., Forrester, J. V., Wilson, H. M., Mody, N., Delibegovic, M. (2014) Myeloid-cell protein tyrosine phosphatase-1B deficiency in mice protects against high-fat diet and lipopolysaccharideinduced inflammation, hyperinsulinemia, and endotoxemia through an IL-10 STAT3-dependent mechanism. Diabetes 63, 456-470.